Janney Montgomery Scott LLC increased its position in shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA – Get Rating) by 6.9% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 141,948 shares of the real estate investment trust after purchasing an additional 9,179 shares during the period. Janney Montgomery Scott LLC owned approximately 0.06% of Sabra Health Care REIT valued at $1,862,000 at the end of the most recent reporting period.
A number of other large investors have also recently increased or decreased their holdings in SBRA. Point72 Hong Kong Ltd purchased a new position in Sabra Health Care REIT during the second quarter for approximately $31,000. JFS Wealth Advisors LLC purchased a new position in Sabra Health Care REIT during the second quarter for approximately $32,000. Lazard Asset Management LLC purchased a new position in Sabra Health Care REIT during the second quarter for approximately $38,000. Lindbrook Capital LLC increased its holdings in Sabra Health Care REIT by 60.8% during the second quarter. Lindbrook Capital LLC now owns 2,929 shares of the real estate investment trust worth $41,000 after purchasing an additional 1,107 shares in the recent quarter. Finally, Worth Asset Management LLC purchased a new position in Sabra Health Care REIT during the first quarter for approximately $44,000. Institutional investors own 87.20% of the company’s shares.
Wall Street analysts expect growth
SBRA has been the subject of a number of recent research reports. StockNews.com began coverage of the shares of Sabra Health Care REIT in a research note on Wednesday, Oct. 12. They set a “hold” rating for the company. Bank of America downgraded shares of Sabra Health Care REIT from a “neutral” rating to an “underperform” rating and cut their price target for the stock from $15.00 to $13.00 in a research note Monday 14 November. JMP Securities downgraded shares of Sabra Health Care REIT from an “outperform” rating to a “market perform” rating in a research note on Tuesday, December 13. Finally, Robert W. Baird downgraded shares of Sabra Health Care REIT from an “outperform” rating to a “neutral” rating and set a $13.00 price target for the company. in a research note on Monday 10 October. One analyst rated the stock with a sell rating, eight gave a hold rating, and two gave the company a buy rating. According to data from MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $15.00.
Sabra Health Care REIT Trading Down 1.1%
NASDAQ:SBRA shares opened at $13.12 on Friday. Sabra Health Care REIT, Inc. has a 52-week low of $11.44 and a 52-week high of $16.60. The company has a market cap of $3.03 billion, a P/E ratio of -164.00, and a beta of 1.26. The company has a 50-day simple moving average of $12.64 and a 200-day simple moving average of $13.71. The company has a debt-to-equity ratio of 0.76, a fast ratio of 2.90, and a current ratio of 2.90.
Sabra Health Care REIT Dividend Announcement
The company also recently declared a quarterly dividend, which was paid on Wednesday, Nov. 30. Shareholders of record on Thursday, Nov. 17 received a $0.30 dividend. The ex-dividend date was Wednesday 16 November. This represents an annualized dividend of $1.20 and a yield of 9.15%. Sabra Health Care REIT’s dividend payout ratio currently stands at -1,500.00%.
About Sabra Health Care REIT
(Get Rating)
As of March 31, 2022, Sabra’s investment portfolio comprised 416 properties held for investment purposes. These are (i) 279 transitional/skilled nursing facilities, (ii) 59 senior housing communities (Leased), (iii) 50 senior housing communities managed by third party property managers under to Senior Housing – Managed arrangements, (iv) 13 Behavioral Health Facilities and (v) 15 Specialty Hospitals and Other Facilities), a business held for sale, an investment in a commercial lease, 16 investments in loan assets (consisting of (i) two mortgage loans, (ii) a construction loan and (iii) 13 other loans), seven preferred interests and an investment in an unconsolidated joint venture.
Further reading
This instant news alert was powered by MarketBeat’s narrative science technology and financial data to provide readers with the fastest and most accurate reports. This story was reviewed by the MarketBeat editorial team prior to publication. Please send any questions or comments about this story to [email protected]
Before you consider Sabra Health Care REIT, you’ll want to hear this.
MarketBeat tracks Wall Street’s top-rated and best-performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat identified the five stocks that top analysts are whispering to their clients to buy now before the broader market catches on…and Sabra Health Care REIT was not on the list.
Although Sabra Health Care REIT currently has a “Hold” rating among analysts, top-rated analysts believe these five stocks are better buys.
View the five titles here
